Unlocking the potential of direct-to-patient as decentralised trials continue to grow
Pharmaceutical Technology
JUNE 23, 2022
This challenging environment, in addition to the measures taken to restrict people’s movement in order to reduce the viruses spread, led to many of the vital clinical trials being carried out to shift towards decentralised trial procedures that utilised virtual medicine and direct-to-patient (DtP) drug delivery.
Let's personalize your content